R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Price:
1 182
ILS
0.6%
Market Closed
Market Cap:
₪139.9m
Relative Value
The Relative Value of one REKA stock under the Base Case scenario is hidden ILS. Compared to the current market price of 1 182 ILS, Rekah Pharmaceutical Industry Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
REKA Relative Value
HIDDEN
Multiples Across Competitors
REKA Competitors Multiples
Rekah Pharmaceutical Industry Ltd Competitors
Rekah Pharmaceutical Industry Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IL |
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
139.9m ILS | 0.5 | -9.9 | 9.7 | -64.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
932.1B USD | 14.3 | 45.2 | 30.4 | 32.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.5B USD | 6.2 | 21.8 | 15.1 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
257.3B CHF | 4.2 | 19.8 | 11.7 | 13.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
223.5B GBP | 5.1 | 29.3 | 16.3 | 22.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.6B CHF | 5.3 | 21.5 | 13.3 | 17.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
285.2B USD | 4.4 | 15.6 | 9.7 | 11.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.7 | 8 | 9.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.4B USD | 2.4 | 19.5 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.2B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
